Ling Geng
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- Angiogenesis and VEGF in Cancer 14
- PI3K/AKT/mTOR signaling in cancer 7
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 3
- Protein Kinase Regulation and GTPase Signaling 2
-
- Cancer, Hypoxia, and Metabolism 10
- Co-authors
- Dennis E. Hallahan (31 shared papers)Allie Fu (15 shared papers)Edwin F. Donnelly (7 shared papers)Carolyn Cao (7 shared papers)Jeffrey M. Albert (6 shared papers)Gerald McMahon (3 shared papers)Kwang Woon Kim (4 shared papers)Kyle C. Cuneo (8 shared papers)
- Journals
- Cancer Research (9 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)Clinical Cancer Research (3 papers)Nature Medicine (2 papers)Cytokine (2 papers)
- Partner nations
- United StatesChinaPortugal
In The Last Decade
Ling Geng
50 papers receiving 3.1k citations
Ling Geng's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 739
- Oncology 835
- Molecular Biology 1.7k
- Genetics 184
- Immunology and Allergy 104
Countries citing papers authored by Ling Geng
This map shows the geographic impact of Ling Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Geng more than expected).
Fields of papers citing papers by Ling Geng
This network shows the impact of papers produced by Ling Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Geng. The network helps show where Ling Geng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Geng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models Hit paper breakdown → | 2018 | 391 |
| 2 | Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. | 2001 | 280 |
| 3 | 2006 | 276 | |
| 4 | SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. | 2003 | 226 |
| 5 | 2007 | 215 | |
| 6 | 2006 | 145 | |
| 7 | Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. | 2002 | 132 |
| 8 | 2004 | 128 | |
| 9 | 2003 | 110 | |
| 10 | 2006 | 102 | |
| 11 | 2005 | 101 | |
| 12 | 2009 | 71 | |
| 13 | 2006 | 70 | |
| 14 | 2008 | 68 | |
| 15 | 2001 | 68 | |
| 16 | 2008 | 59 | |
| 17 | 2010 | 51 | |
| 18 | 2006 | 46 | |
| 19 | 2005 | 44 | |
| 20 | 2004 | 40 |
About Ling Geng
Ling Geng is a scholar working on Molecular Biology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 3.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (14 papers), Cancer, Hypoxia, and Metabolism (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), DNA Repair Mechanisms (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cancer Research (739 citations), Oncology (835 citations), Molecular Biology (1.7k citations), Genetics (184 citations) and Immunology and Allergy (104 citations). Ling Geng has collaborated with scholars based in United States, China and Portugal. Frequent co-authors include Dennis E. Hallahan, Allie Fu, Edwin F. Donnelly, Carolyn Cao, Jeffrey M. Albert, Gerald McMahon, Kwang Woon Kim, Kyle C. Cuneo, Jiahong Lu and Konjeti R. Sekhar. Their work appears in journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Nature Medicine and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.